INS and metabolic syndrome: We could demonstrate that GMP, a milk-protein-derived peptide, is endowed with the potential to fight OxS, inflammation, intestinal lipoprotein production, and alterations of the insulin signaling pathways leading to postprandial dyslipidemia.